A Study of Effects of Selpercatinib (LY3527723) on Midazolam in Healthy Participants
Clinical trial NCT05338476 · COMPLETED
Trial details
- NCT number
- NCT05338476
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-12
- Primary completion
- 2018-08-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.